Virtual Presentation

Clinical Issues and Future Directions in Hematologic Malignancies: Non-Hodgkin’s Lymphoma

Source: Clinical Issues and Future Directions in Hematologic Malignancies

Clinical Issues and Future Directions in Hematologic Malignancies: Non-Hodgkin’s Lymphoma


Faculty:

  • Owen A. O'Connor, MD, PhD

CME CREDIT INFORMATION

Release Date: 04/05/07

Expiration Date: 04/04/08


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Registered Nurses: 1.0 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review the results of recent studies on the use of FDA-approved and investigational agents for the treatment of non-Hodgkin’s lymphoma
  • Discuss new insights into the etiology and pathogenesis of non-Hodgkin’s lymphoma
  • Summarize the use of prognostic markers in the management of non-Hodgkin’s lymphoma

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.